Former Israeli Prime Minister Ehud Olmert Joins Medical Cannabis Company Univo

Univo
Pharmaceuticals Ltd (TASE: UNVO.TA) (https://www.unvmed.com),
the one-stop-shop solution for medical cannabis from seed to market,
announces today that former Israeli Prime Minister Ehud Olmert is
joining the company as an investor and professional advisor.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20190416005790/en/

(Photo: Ehud Olmert)

This news follows recent Univo achievements since the beginning of 2019,
such as the securing of all four licenses for the cultivation, research
and development, production, and distribution of its own cannabis
products; assuming ownership of 74% of the Amit Cannabis growth farm;
and signing an exclusive agreement to develop the formulation for
Veoli’s new cannabis inhaler. Univo is currently traded on the Tel Aviv
Stock exchange.

The addition of Ehud Olmert to a leading medical cannabis company builds
on his vast experience in the health space. Olmert is currently the head
of Israel’s Public Council for Healthy Lifestyles, and he leads a
private VC that invests in top medical technology companies in Israel.
As Israel’s Minister of Health from 1990-1992, Olmert spearheaded
well-known reforms, such as the legislation of the National Health
Insurance law. Olmert will contribute his vast experience and help
promote Univo’s business goals both in Israel and globally, and will
support the company’s future fundraising efforts.

Univo conducts all of its research in-house and will continue
development in its new 750m² facility, which includes an on-site R&D
laboratory. Using this facility, Univo will continue to grow
high-quality cannabis while developing a diverse product line using
innovative technologies and unique medical cannabis strain genetics.
Univo’s achievements in the medical cannabis space will help Israel
become a focal point for medical cannabis development worldwide.

“The tech revolution has entered the medical cannabis space and is
expediting all R&D, manufacturing, and even regulatory procedures, with
the goal of relieving pain for patients suffering from a spectrum of
diseases,” says former Israeli Prime Minister Ehud Olmert. “Israel is
stepping up and joining the world’s most progressive nations in
developing a pivotal local industry that has the potential to contribute
to global medical cannabis R&D efforts. After I examined Israel’s top
medical cannabis companies, I chose to contribute my experience and
knowledge to Univo, because I believe that Univo has the best chance of
becoming an independent entity when it comes to manufacturing and
distributing top cannabis-based products. I am thankful for the
opportunity to step in and help this company become a global leader.”

“I am proud of this partnership with a fierce leader with a
distinguished track record,” says Ido Hagag, one of Univo’s key
investors. “I have no doubt that Mr. Olmert’s connections with global
markets and his capabilities in the health sector will help steer our
company towards improving patient care world wide.”

“After Mr. Ehud Olmert took a close look at the top names in the Israeli
medical cannabis sector, and after visiting our factory, which is the
most technologically advanced when it comes to manufacturing and
distributing cannabis-based products to the world, he had no doubt he
would choose to work with Univo exclusively. We’re proud to have Mr.
Olmert supporting our vision and putting his trust in our manufacturing
and supply chain. This is a major milestone for Univo that soon enough
will bear fruit.”

About Univo: https://www.unvmed.com

Leadership:
Golan Bitton - co-Founder and CEO
Yossi
Hatan - CFO
Dr. Shaul Mukhtar- consulting
Dr. Ilana Lavon -
VP, R&D
Omer Layani - Formulator, R&D Advisor

View source version on businesswire.com: https://www.businesswire.com/news/home/20190416005790/en/